Chloe Stengel-Tosetti is an accomplished molecular biologist, oncologist, and healthcare management professional. She holds a Master of Science (MSc) in Molecular Biology from the Université des Sciences Poitiers, where she delved deep into the intricacies of life at the cellular level. Her curiosity regarding the pervasive nature of cancer led her to pursue an interdisciplinary Doctor of Philosophy (PhD) in Oncology and Cancer Biology at Imperial College London.

In addition to her scientific expertise, Chloe is a skilled healthcare consultant with a Master of International Health Care Management, Economics and Policy, Cum Laude. She has worked at Simon-Kucher & Partners and Dolon Ltd, where she provided strategic guidance to healthcare providers and pharmaceutical companies looking to navigate a complex regulatory landscape.

Chloe's passion for advancing cancer research has driven her to work in multiple research settings, including Breakthrough Breast Cancer, UCL Cancer Institute, and Imperial College London. Through her research work, she has developed a deep understanding of cancer biology and the mechanisms that drive tumor growth, which she leverages in her healthcare consulting work.

With a broad range of experience and a diverse set of interdisciplinary skills, Chloe is a well-rounded professional with a deep understanding of the healthcare industry. She is equally at home in the laboratory and in the boardroom, making her a valuable asset in any professional setting.